Literature DB >> 23814123

Severe parainfluenza pneumonia in a case of transient hypogammalobulinemia of infancy.

Nicola Cotugno1, Emma Concetta Manno, Francesca Stoppa, Serena Sinibaldi, Claudia Saffirio, Parizia D'Argenio, Marco Marano, Matteo Di Nardo, Paolo Palma.   

Abstract

Human parainfluenza viruses (HPIVs) infection, largely known to cause self-limiting bronchiolitis and pneumonia in immune competent patients, can lead to severe to fatal pulmonary disease in immune disorders, such as primary or acquired-immune deficiencies. We report the case of a 1-year-old child who developed an acute respiratory distress syndrome. Because of a progressive respiratory failure unresponsive to conventional treatment extracorporeal membrane oxygenation (ECMO) was rapidly started. HPIV-3 infection was diagnosed on the rhinopharyngeal fluid and immunological examinations revealed a hypogammaglobulinemia. A combination therapy with ribavirin, intravenous immunoglobulin (IVIG) and steroid under ECMO support was started with considerable improvement. Subsequent analysis and more specific immunological assessment resulted normal confirming the diagnosis of transient hypogammaglobulinemia of infancy (THI). This case highlights the importance of prompt therapy with early ECMO support in combination with ribavirin, IVIG and steroids in patients affected by severe HPIV-3 pneumonia and THI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23814123      PMCID: PMC3703058          DOI: 10.1136/bcr-2013-009959

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

Review 1.  Respiratory syncytial virus and parainfluenza virus.

Authors:  C B Hall
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

2.  Transitory hypogammaglobulinemia of infancy in FG syndrome.

Authors:  A Finocchi; P Palma; P Rossi; J M Opitz; G Neri
Journal:  Am J Med Genet A       Date:  2005-11-01       Impact factor: 2.802

3.  CpG drives human transitional B cells to terminal differentiation and production of natural antibodies.

Authors:  Federica Capolunghi; Simona Cascioli; Ezio Giorda; Maria Manuela Rosado; Alessandro Plebani; Cinzia Auriti; Giulio Seganti; Roberta Zuntini; Simona Ferrari; Maria Cagliuso; Isabella Quinti; Rita Carsetti
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

Review 4.  Paramyxovirus strategies for evading the interferon response.

Authors:  Bin Gotoh; Takayuki Komatsu; Kenji Takeuchi; Junko Yokoo
Journal:  Rev Med Virol       Date:  2002 Nov-Dec       Impact factor: 6.989

5.  Transient hypogammaglobulinemia of infancy: clinical and immunologic features of 40 new cases.

Authors:  S S Kiliç; I Tezcan; O Sanal; A Metin; F Ersoy
Journal:  Pediatr Int       Date:  2000-12       Impact factor: 1.524

6.  Long-term therapy with aerosolized ribavirin for parainfluenza 3 virus respiratory tract infection in an infant with severe combined immunodeficiency.

Authors:  Jitka Stankova; Anne-Sophie Carret; Dorothy Moore; Christine McCusker; David Mitchell; Michael Davis; Bruce Mazer; Nada Jabado
Journal:  Pediatr Transplant       Date:  2007-03

7.  Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children < 5 years old.

Authors:  G Reed; P H Jewett; J Thompson; S Tollefson; P F Wright
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

8.  Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience.

Authors:  W G Nichols; T Gooley; M Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2001       Impact factor: 5.742

9.  Inhibition of STAT 1 phosphorylation by human parainfluenza virus type 3 C protein.

Authors:  Achut G Malur; Santanu Chattopadhyay; Ratan K Maitra; Amiya K Banerjee
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 10.  Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.

Authors:  C H Wendt; M I Hertz
Journal:  Semin Respir Infect       Date:  1995-12
View more
  1 in total

Review 1.  Parainfluenza Virus Infection.

Authors:  Angela R Branche; Ann R Falsey
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.